Search research articles
Contact Us
Filters
Showing results (121-130 of 128) with videos related to
Page
of 13
Sort By:
You have reached the last page of results.
This site can display upto 128 results.
BMJ Open
|
December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK
Christopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
International Journal of Neonatal Screening
|
April 25, 2022
Improving Recruitment for a Newborn Screening Pilot Study with Adaptations in Response to the COVID-19 Pandemic
Julia Wynn, Norma P Tavakoli, Niki Armstrong, et al.
European Journal of Human Genetics : EJHG
|
June 14, 2012
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder
Bradley N Smith, Stephen Newhouse, Aleksey Shatunov, et al.
JAMA Neurology
|
June 1, 2016
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
Isabella Fogh, Kuang Lin, Cinzia Tiloca, et al.
Genome Research
|
September 10, 2017
Detection of long repeat expansions from PCR-free whole-genome sequence data
Egor Dolzhenko, Joke J F A van Vugt, Richard J Shaw, et al.
Neurobiology of Aging
|
September 11, 2012
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1
Kreshnik B Ahmeti, Senda Ajroud-Driss, Ammar Al-Chalabi, et al.
Human Molecular Genetics
|
November 22, 2013
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis
Isabella Fogh, Antonia Ratti, Cinzia Gellera, et al.
Cell Genomics
|
October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
Page
of 13
Search research articles
Search
Showing results (121-130 of 128) with videos related to
Sort By:
Page
of 13
You have reached the last page of results.
This site can display upto 128 results.
BMJ Open
|
December 9, 2024
Macrophage Therapy for Acute Liver Injury (MAIL): a study protocol for a phase 1 randomised, open-label, dose-escalation study to evaluate safety, tolerability and activity of allogeneic alternatively activated macrophages in patients with paracetamol-induced acute liver injury in the UK
Christopher Humphries, Melisande Addison, Guruprasad Aithal, et al.
International Journal of Neonatal Screening
|
April 25, 2022
Improving Recruitment for a Newborn Screening Pilot Study with Adaptations in Response to the COVID-19 Pandemic
Julia Wynn, Norma P Tavakoli, Niki Armstrong, et al.
European Journal of Human Genetics : EJHG
|
June 14, 2012
The C9ORF72 expansion mutation is a common cause of ALS+/-FTD in Europe and has a single founder
Bradley N Smith, Stephen Newhouse, Aleksey Shatunov, et al.
JAMA Neurology
|
June 1, 2016
Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis
Isabella Fogh, Kuang Lin, Cinzia Tiloca, et al.
Genome Research
|
September 10, 2017
Detection of long repeat expansions from PCR-free whole-genome sequence data
Egor Dolzhenko, Joke J F A van Vugt, Richard J Shaw, et al.
Neurobiology of Aging
|
September 11, 2012
Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1
Kreshnik B Ahmeti, Senda Ajroud-Driss, Ammar Al-Chalabi, et al.
Human Molecular Genetics
|
November 22, 2013
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis
Isabella Fogh, Antonia Ratti, Cinzia Gellera, et al.
Cell Genomics
|
October 22, 2024
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, et al.
Page
of 13